Who is sponsoring NCT03727815?

NCT03727815 is sponsored by Johns Hopkins University.

What drugs are being tested in NCT03727815?

Interventions in NCT03727815: Mindfulness Pain Management Arm, Mindfulness Self Esteem Arm.

What condition does NCT03727815 study?

NCT03727815 studies Nose Deformity.

Is NCT03727815 still recruiting?

NCT03727815 is currently withdrawn. Last updated 5 March 2021.

Last reviewed 2021-03-05 · How we verify

NCT03727815

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Mindfulness Meditation on Rhinoplasty Outcomes

Withdrawn NA Last updated 5 March 2021

What this trial tests

NA trial testing Mindfulness Pain Management Arm in Nose Deformity. Withdrawn.

Timeline

1 January 2021

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	Johns Hopkins University
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Start date	1 January 2021
Primary completion	31 December 2022
Estimated completion	31 December 2022
Sites	2 locations across United States

Drugs / interventions tested

Mindfulness Pain Management Arm
Mindfulness Self Esteem Arm

Conditions studied

Nose Deformity — all drugs for Nose Deformity →

Sponsor

Johns Hopkins University

Who can join

18 and older, any sex, with Nose Deformity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A key factor in determining success of facial plastic plastic surgery is overall patient satisfaction. While a number of patient-reported outcomes tools has been developed, there is still limited research in how physicians can improve patient satisfaction and post-operative outcomes. The goal of this study is to investigate the effect of a mindfulness meditation phone application on rhinoplasty outcomes. This study will also explore whether mindfulness meditation is a feasible adjunct to current pharmacological modalities of postoperative pain control as well as its potential impact on patient satisfaction. These questions will be answered using a randomized controlled trial.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Johns Hopkins University trials

Trials by the same sponsor.

NCT06236542 — Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety · NA · not yet recruiting
NCT07532252 — Daridorexant for Alcohol Use Disorder · Phase 2 · not yet recruiting
NCT06687655 — Impact of Exogenous Ketones on Sleep Apnea · Phase 1, PHASE2 · not yet recruiting
NCT07079111 — 3D Printed Occlusal Splints for Intraoperative Use · NA · not yet recruiting
NCT02998502 — The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03727815 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins University
Last refreshed: 5 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03727815.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing